Chitosan as a nonviral gene delivery system. Structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo

Chitosan is a natural cationic linear polymer that has recently emerged as an alternative nonviral gene delivery system. We have established the relationships between the structure and the properties of chitosan-pDNA polyplexes in vitro. Further, we have compared polyplexes of ultrapure chitosan (UPC) of preferred molecular structure with those of optimised polyethylenimine (PEI) polyplexes in vitro and after intratracheal administration to mice in vivo. Chitosans in which over two out of three monomer units carried a primary amino group formed stable colloidal polyplexes with pDNA. Optimized UPC and PEI polyplexes protected the pDNA from serum degradation to approximately the same degree, and they gave a comparable maximal transgene expression in 293 cells. In contrast to PEI, UPC was non toxic at escalating doses. After intratracheal administration, both polyplexes distributed to the mid-airways, where transgene expression was observed in virtually every epithelial cell, using a sensitive pLacZ reporter containing a translational enhancer element. However, the kinetics of gene expression differed – PEI polyplexes induced a more rapid onset of gene expression than UPC. This was attributed to a more rapid endosomal escape of the PEI polyplexes. Although this resulted in a more efficient gene expression with PEI polyplexes, UPC had an efficiency comparable to that of commonly used cationic lipids. In conclusion, this study provides insights into the use of chitosan as a gene delivery system. It emphasises that chitosan is a nontoxic alternative to other cationic polymers and it forms a platform for further studies of chitosan-based gene delivery systems.

[1]  W. Mark Saltzman,et al.  Synthetic DNA delivery systems , 2000, Nature Biotechnology.

[2]  Joseph Zabner,et al.  Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid (*) , 1995, The Journal of Biological Chemistry.

[3]  Johnf . Thompson,et al.  Modulation of firefly luciferase stability and impact on studies of gene regulation. , 1991, Gene.

[4]  P. Liljeström,et al.  Enhancing immune responses using suicidal DNA vaccines , 1998, Nature Biotechnology.

[5]  Alton,et al.  Cystic fibrosis clinical trials. , 1998, Advanced drug delivery reviews.

[6]  O. Smidsrod,et al.  Determination of enzymatic hydrolysis specificity of partially N-acetylated chitosans. , 1996, Biochimica et biophysica acta.

[7]  A. Mikos,et al.  Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency , 1999, Gene Therapy.

[8]  R. Mumper,et al.  Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[9]  O. Smidsrod,et al.  Preparative and analytical size-exclusion chromatography of chitosans , 1996 .

[10]  D. Putnam,et al.  Design of imidazole-containing endosomolytic biopolymers for gene delivery. , 2000, Biotechnology and bioengineering.

[11]  M. Cotten,et al.  Mannose Polyethylenimine Conjugates for Targeted DNA Delivery into Dendritic Cells* , 1999, The Journal of Biological Chemistry.

[12]  P. Cullis,et al.  Nomenclature for synthetic gene delivery systems. , 1997, Human gene therapy.

[13]  M. Stedman,et al.  Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes. , 1999, Human gene therapy.

[14]  D. Escande,et al.  Polyethylenimine but Not Cationic Lipids Promotes Transgene Delivery to the Nucleus in Mammalian Cells* , 1998, The Journal of Biological Chemistry.

[15]  R. Duncan,et al.  Evaluation of the biological properties of soluble chitosan and chitosan microspheres , 1997 .

[16]  R. Wattiaux,et al.  Endosomes, lysosomes: their implication in gene transfer. , 2000, Advanced drug delivery reviews.

[17]  M. Monsigny,et al.  Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells. , 1999, Human gene therapy.

[18]  I. Tubulekas,et al.  Alphavirus expression vectors and their use as recombinant vaccines: a minireview. , 1997, Gene.

[19]  M. Ichelpeuchmaur Gene transfer by guanidinium-cholesterol cationic lipids into airway epithelial cells in vitro and in vivo , 1997 .

[20]  C. Benoist,et al.  A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. , 1996, Human gene therapy.

[21]  F. Szoka,et al.  The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes , 1997, Gene Therapy.

[22]  J. Dubochet,et al.  Cryo-electron microscopy of vitrified specimens , 1988, Quarterly Reviews of Biophysics.

[23]  S. Harding,et al.  Hydrodynamic characterization of chitosans varying in degree of acetylation. , 1993, International journal of biological macromolecules.

[24]  R. Boucher,et al.  Status of gene therapy for cystic fibrosis lung disease. , 1999, The Journal of clinical investigation.

[25]  Lisbeth Ilium,et al.  Chitosan and Its Use as a Pharmaceutical Excipient , 1998, Pharmaceutical Research.

[26]  L. Huang,et al.  In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes , 1997, Gene Therapy.

[27]  A. Domard pH and c.d. measurements on a fully deacetylated chitosan: application to CuII—polymer interactions , 1987 .

[28]  A. Mikos,et al.  Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. , 1999, Journal of biomedical materials research.

[29]  K. Leong,et al.  DNA-polycation nanospheres as non-viral gene delivery vehicles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[30]  R. Kumar,et al.  Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. , 1994, The Journal of biological chemistry.

[31]  L. Huang,et al.  Protamine sulfate enhances lipid-mediated gene transfer , 1997, Gene Therapy.

[32]  O. Smidsrod,et al.  Degradation of partially N-acetylated chitosans with hen egg white and human lysozyme , 1996 .

[33]  Chitosan,et al.  Advances in chitin and chitosan , 1992 .

[34]  C. Pouton,et al.  Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[35]  A. Mikos,et al.  Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Ferrari,et al.  ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo , 1997, Gene Therapy.

[37]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[38]  K Möller,et al.  Short technical reports. Effects of lipopolysaccharide on transfection efficiency in eukaryotic cells. , 1995, BioTechniques.

[39]  R. Scheule,et al.  Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. , 1996, Human gene therapy.

[40]  A. Boletta,et al.  Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs , 1999, Gene Therapy.

[41]  L E Scriven,et al.  Controlled environment vitrification system: an improved sample preparation technique. , 1988, Journal of electron microscopy technique.

[42]  J. Kaplan,et al.  Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells. , 2000, Human gene therapy.

[43]  J. Isaacs,et al.  Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium , 1999, Gene Therapy.

[44]  O. Smidsrod,et al.  13C-n.m.r. studies of the acetylation sequences in partially N-deacetylated chitins (chitosans). , 1991, Carbohydrate research.

[45]  O. Smidsrod,et al.  Compositional heterogeneity of heterogeneously deacetylated chitosans , 1996 .

[46]  V. Bloomfield DNA condensation by multivalent cations. , 1997, Biopolymers.

[47]  H Lennernäs,et al.  Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[48]  D. Liggitt,et al.  In situ histochemical detection of beta-galactosidase activity in lung: assessment of X-Gal reagent in distinguishing lacZ gene expression and endogenous beta-galactosidase activity. , 1997, Human gene therapy.

[49]  T. Ochiya,et al.  New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet , 1999, Nature Medicine.

[50]  J. Jessee,et al.  Direct gene transfer to the respiratory tract of mice with pure plasmid and lipid-formulated DNA. , 1998, Antisense & nucleic acid drug development.

[51]  S. Jacob Endothelium , 2002, Surgical Anatomy for Endothelial Keratoplasty.

[52]  C. K. Chan,et al.  Enhancement of polylysine-mediated transferrinfection by nuclear localization sequences: polylysine does not function as a nuclear localization sequence. , 1999, Human gene therapy.

[53]  L. Soroceanu,et al.  In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer , 1997, Nature Biotechnology.

[54]  Krishnendu Roy,et al.  Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.

[55]  P. Artursson,et al.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.

[56]  M. Conese,et al.  Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs , 2000, Gene Therapy.

[57]  P. Felgner Improvements in cationic liposomes for in vivo gene transfer. , 1996, Human gene therapy.

[58]  Abdallah,et al.  Gene transfer with lipospermines and polyethylenimines. , 1998, Advanced drug delivery reviews.

[59]  C. Wilcox,et al.  Long-term expression in sensory neurons in tissue culture from herpes simplex virus type 1 (HSV-1) promoters in an HSV-1-derived vector , 1995, Journal of virology.

[60]  F. Szoka,et al.  Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer–plasmid complexes , 1999, Gene Therapy.